Back
Arrowhead Pharmaceuticals Stock Predictions
Sponsored
ARWR
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.14
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerArrowhead Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Arrowhead Pharmaceuticals has on average historically risen by 51.8% based on the past 29 years of stock performance.
- Arrowhead Pharmaceuticals has risen higher in 12 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.38%
-
Is Arrowhead Pharmaceuticals Stock Undervalued?
The current Arrowhead Pharmaceuticals [ARWR] share price is $20.78. The Score for ARWR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - ARWR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Arrowhead Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Arrowhead Pharmaceuticals has on average historically risen by 51.8% based on the past 29 years of stock performance.
Arrowhead Pharmaceuticals Stock Rating
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals overpriced?
- Arrowhead Pharmaceuticals has risen higher in 12 of those 29 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.38%
Arrowhead Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arrowheadpharma.com
52-Week Data
52-Week High:
39.83
52-Week Low:
19.44
Prediction Charts
Market Cap:
2.58B
Price in USD:
20.78
Volume:
1.37M
Beta:
1.64
Technical Analysis
SMA50:
24.98
SMA100:
24.82
SMA200:
27.23
52-Wk Change:
-26.13%
Stock Predictions
-
Is Arrowhead Pharmaceuticals stock public?
Yes, Arrowhead Pharmaceuticals is a publicly traded company. -
What is the Arrowhead Pharmaceuticals stock quote today?
The Arrowhead Pharmaceuticals stock price is 20.78 USD today. -
How to buy Arrowhead Pharmaceuticals stock online?
You can buy Arrowhead Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 24.24 | 24.08 | 24.67 | 23.96 |
Aug-30 | 24.12 | 23.83 | 24.28 | 23.24 |
Sep-3 | 24.02 | 22.92 | 24.77 | 22.82 |
Sep-4 | 22.70 | 23.98 | 24.09 | 22.65 |
Sep-5 | 24.20 | 23.27 | 24.20 | 23.07 |
Sep-6 | 23.25 | 22.22 | 23.44 | 21.98 |
Sep-9 | 22.18 | 21.76 | 22.53 | 21.45 |
Sep-10 | 22.00 | 21.47 | 22.23 | 21.38 |
Sep-11 | 21.32 | 20.95 | 21.32 | 20.63 |
Sep-12 | 20.90 | 20.24 | 21.10 | 20.14 |
Sep-13 | 20.39 | 21.49 | 21.90 | 20.39 |
Sep-16 | 21.50 | 20.45 | 21.73 | 20.41 |
Sep-17 | 20.60 | 20.01 | 20.71 | 19.44 |
Sep-18 | 20.00 | 20.78 | 21.36 | 19.79 |
Arrowhead Pharmaceuticals Earnings
Arrowhead Pharmaceuticals Earnings Report: Per Share Arrowhead Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arrowhead Pharmaceuticals Forecast Revenue Growth
Arrowhead Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Arrowhead Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.51 per share, an increase next quarter of $0.05 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.